Results 191 to 200 of about 43,404 (216)

Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial

Lancet, The, 2021
Galia Rahav, Dong-Gun Lee, Alfredo Ponce-de-Leon   +2 more
exaly  

Voriconazole

Reactions Weekly, 2017
openaire   +2 more sources

Voriconazole

Reactions Weekly, 2015
  +4 more sources

Voriconazole pharmacogenetics – Authors' reply

Lancet, The, 2021
exaly  

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Lancet, The, 2016
Thomas F Patterson, Dimitrios P Kontoyiannis, Oliver A Cornely   +2 more
exaly  

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

New England Journal of Medicine, 2002
Raoul Herbrecht, Thomas F Patterson, Olivier Lortholary   +2 more
exaly  

Voriconazole

Reactions Weekly, 2008
openaire   +1 more source

Voriconazole

Reactions Weekly, 2023
openaire   +1 more source

Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study

Clinical Infectious Diseases, 2019
Robbert G Bentvelsen, Alexander F A D Schauwvlieghe, Steven Schalekamp   +2 more
exaly  

Voriconazole

Reactions Weekly, 2010
openaire   +1 more source